0001181431-13-010283.txt : 20130219
0001181431-13-010283.hdr.sgml : 20130219
20130215203521
ACCESSION NUMBER: 0001181431-13-010283
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130215
FILED AS OF DATE: 20130215
DATE AS OF CHANGE: 20130215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIMONTON PAMELA A
CENTRAL INDEX KEY: 0001202103
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 13621204
MAIL ADDRESS:
STREET 1: C/O EXELIXIS INC
STREET 2: 170 HARBOR WAY
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94083
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 E. GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 210 E. GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
rrd370504.xml
X0306
4
2013-02-15
0
0000939767
EXELIXIS, INC.
EXEL
0001202103
SIMONTON PAMELA A
C/O EXELIXIS, INC.
210 E. GRAND AVE.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
EVP and General Counsel
Common Stock
2013-02-15
4
M
0
1875
0
A
14507
D
Common Stock
2013-02-15
4
F
0
879
0
D
13628
D
Common Stock
8386
I
By 401(K)
Restricted Stock Units
2013-02-15
4
M
0
1875
D
Common Stock
1875
9375
D
Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On December 9, 2009, the reporting person was granted 30,000 restricted stock units, of which 1/16th of the shares subject to the restricted stock units vested on February 15, 2013. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on December 11, 2009.
The reporting person is reporting the withholding by Exelixis, Inc. of 879 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of the Converted Common Stock to the reporting person on February 15, 2013.
Represents 8,386 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 14, 2013.
Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock.
On December 9, 2009, the reporting person was granted 30,000 restricted stock units, of which 1/16th of the shares subject to the restricted stock units vested on February 15, 2013. The common stock into which such vested restricted stock units converted on February 15, 2013 is reported in Table I on this Form 4. The remaining unvested restricted stock units will continue to vest as to 1/16th of the original number of shares subject to the restricted stock units on each succeeding May 15, August 15, November 15 and February 15 until fully vested.
/s/ James B. Bucher, Attorney in Fact
2013-02-15